ELISE CONDOR: Open Payments
NPI 1326561515 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,348 in 96 payments from 11 companies in 2025. Trend: 2023 $612 · 2024 $391 · 2025 $2,348
Food & beverage: $2,348
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $399 |
| Axsome Therapeutics, Inc. | 9 | $329 |
| Janssen Pharmaceuticals, Inc | 8 | $281 |
| Vanda Pharmaceuticals Inc. | 9 | $265 |
| Otsuka America Pharmaceutical, Inc. | 11 | $250 |
| E.R. Squibb & Sons, L.L.C. | 8 | $220 |
| Lundbeck LLC | 8 | $211 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $179 |
| Neurocrine BioSciences, Inc. | 5 | $134 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
Products named: REXULTI, VRAYLAR, Auvelity, SPRAVATO, COBENFY, TRINTELLIX, FANAPT, INGREZZA.
Industry payments across NY — which companies pay providers there.
